Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.070
-0.180 (-4.24%)
Sep 15, 2025, 4:00 PM EDT - Market closed
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $126.12 million as of September 15, 2025. Its market cap has decreased by -31.53% in one year.
Market Cap
126.12M
Enterprise Value
77.91M
1-Year Change
-31.53%
Ranking
Category
Stock Price
$4.07
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $126.12M, a decrease of -64.58%. That is a compound annual growth rate of -51.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 126.10M | 46.80% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |